Neurocrine Bioscienc
(NBIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,822 | -19,950 | 5,120 | 5,874 | -3,346 |
| Depreciation Amortization | 2,066 | 1,720 | 1,320 | 981 | 715 |
| Accounts receivable | -752 | N/A | N/A | N/A | N/A |
| Other Working Capital | 2,999 | -2,330 | 1,820 | -757 | 874 |
| Other Operating Activity | 2,253 | 9,870 | 2,730 | 583 | -664 |
| Operating Cash Flow | $-10,256 | $-10,690 | $10,990 | $6,681 | $-2,421 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -19,166 | N/A | N/A | N/A | N/A |
| PPE Investments | -2,061 | -3,680 | -6,440 | -1,640 | -47 |
| Other Investing Activity | 0 | 8,380 | -760 | -46,917 | 980 |
| Investing Cash Flow | $-21,227 | $4,700 | $-7,200 | $-48,557 | $933 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 981 | N/A | N/A | N/A | N/A |
| Debt Repayment | -957 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 41,016 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 1,920 | 650 | 46,808 | 3,165 |
| Financing Cash Flow | $41,040 | $1,920 | $650 | $46,808 | $3,165 |
| Beginning Cash Position | 11,708 | 15,770 | 11,320 | 6,393 | 4,716 |
| End Cash Position | 21,265 | 11,700 | 15,770 | 11,325 | 6,393 |
| Net Cash Flow | $9,557 | $-4,060 | $4,440 | $4,932 | $1,677 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,256 | -10,690 | 10,990 | 6,681 | -2,421 |
| Capital Expenditure | -2,061 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -12,317 | -10,690 | 10,990 | 6,681 | -2,421 |